About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Col4a3tm1Jhm
targeted mutation 1, Jeffrey H Miner
MGI:1934893
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Col4a3tm1Jhm/Col4a3tm1Jhm involves: 129S1/Sv * 129X1/SvJ MGI:2176903
cx2
Col4a3tm1Jhm/Col4a3tm1Jhm
Mmp9tm1Tvu/Mmp9tm1Tvu
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ MGI:3510654
cx3
Col4a3tm1Jhm/Col4a3tm1Jhm
Tg(Nphs1-rtTA*3G)8Jhm/0
Tg(tetO-COL4A3/Col4a3)#aJhm/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA MGI:5559180
cx4
Col4a3tm1Jhm/Col4a3tm1Jhm
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(tetO-COL4A3/Col4a3)#aJhm/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA MGI:5559181
cx5
Col4a3tm1Jhm/Col4a3tm1Jhm
Lamb2em1Jhm/Lamb2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J MGI:6378621
cx6
Col4a3tm1Jhm/Col4a3tm1Jhm
Lamb2em1Jhm/Lamb2em1Jhm
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J MGI:6378622


Genotype
MGI:2176903
hm1
Allelic
Composition
Col4a3tm1Jhm/Col4a3tm1Jhm
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Jhm mutation (1 available); any Col4a3 mutation (60 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Kidney abnormalities in Col4a3tm1Jhm/Col4a3tm1Jhm mice

mortality/aging
• most homozygotes die 3 weeks after birth (J:37017)
• only ~5% of homozygotes survive beyond 4 months of age (J:37017)
• mice do not survive beyond 32 weeks (J:207595)

renal/urinary system
• relative levels of urinary protein are similar in mutant and wild-type mice until ~P40, then rise many-fold in mutant mice (J:37017)
• notably, homozygotes do NOT exhibit hematuria (J:37017)
• predominant protein detected in urine is albumin
• at P>65, mutant kidneys appear mottled and wrinkled
• however, at ~5 weeks, mutant kidneys are still externally normal with only minor histological alterations relative to wild-type
• at P40, a few glomeruli exhibit patches of thickened, closed capillary loops
• homozygotes exhibit late-onset, progressive glomerulonephritis, leading to renal failure
• homozygotes exhibit a basket-weave thickening and lamellation of the glomerular basal lamina (BL) (J:37017)
• several changes in the molecular composition of BL are observed; some occur as early as P15 (J:37017)
• decellularized glomerulus basement membrane with a rough and blebby surface (J:207595)
• basket-weave thickening of the glomerular basal lamina (J:37017)
• diffuse (J:207595)
• at P40, homozygotes display accumulation of interstitial cells and extracellular matrix
• at P40, a few glomeruli exhibit retricted segments of thickened Bowman's capsule (crescents) and/or patches of thickened, closed capillary loops (segmental glomerulosclerosis) (J:37017)
• both the number of glomeruli affected and the severity of glomerulosclerotic defects rise subsequently (J:37017)
• at P40, a few glomeruli exhibit retricted segments of thickened Bowman's capsule (crescents)
• at P>65, mutant kidneys appear small relative to wild-type
• at P40, homozygotes display atrophic kidney tubules
• tubular protein cast
• homozygotes display impaired glomerular filtration leading to uremia
• late-onset, progressive glomerulonephritis leading to renal failure
• at P60, homozygotes display increased urinary volume relative to wild-type

homeostasis/metabolism
• in homozygotes, blood creatinine levels rise after P60
• in contrast, creatinine concentrations in urine decline after P60
• a small % of mutants maintain normal levels of blood creatinine and show a mild renal phenotype
• in homozygotes, blood urea nitrogen levels rise after P60, indicating compromised glomerular filtration
• in contrast, urea nitrogen concentrations in urine decline after P60, suggesting a tubular dysfunction
• notably, a small % of homozygotes maintain normal levels of blood urea as late as P100, and exhibit only a mild renal pathology
• relative levels of urinary protein are similar in mutant and wild-type mice until ~P40, then rise many-fold in mutant mice (J:37017)
• notably, homozygotes do NOT exhibit hematuria (J:37017)
• predominant protein detected in urine is albumin

behavior/neurological
• at 2-3 months, most homozygotes become lethargic

growth/size/body
• at 2-3 months, most homozygotes begin to loose weight

hearing/vestibular/ear
• variable penetrance; 3 out of 12 pairs of mutants analyzed showed significantly increased auditory thresholds relative to wild-type
• other mutants showed hearing within normal ranges of thresholds and sensitivities, suggesting that the hearing loss may be due to genetic background differences

immune system
• homozygotes exhibit late-onset, progressive glomerulonephritis, leading to renal failure

cardiovascular system
• at P40, a few glomeruli exhibit patches of thickened, closed capillary loops

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
autosomal recessive Alport syndrome DOID:0110033 OMIM:203780
J:37017 , J:207595




Genotype
MGI:3510654
cx2
Allelic
Composition
Col4a3tm1Jhm/Col4a3tm1Jhm
Mmp9tm1Tvu/Mmp9tm1Tvu
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Jhm mutation (1 available); any Col4a3 mutation (60 available)
Mmp9tm1Tvu mutation (2 available); any Mmp9 mutation (49 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• double homozygotes exhibit no differences in the progression of glomerulonephritis compared with single Col4a3tm1Jhm mutants, suggesting that MMP9 does not play a major role in the progression of Alport syndrome

renal/urinary system
• double homozygotes exhibit no differences in the progression of glomerulonephritis compared with single Col4a3tm1Jhm mutants, suggesting that MMP9 does not play a major role in the progression of Alport syndrome
• at 8 weeks, double homozygotes exhibit the characteristic splitting and thickening of the glomerular basement membrane observed in the Col4a3tm1Jhm mouse model of Alport syndrome
• thickening of the glomerular basement membrane observed at 8 weeks

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
autosomal recessive Alport syndrome DOID:0110033 OMIM:203780
J:63137




Genotype
MGI:5559180
cx3
Allelic
Composition
Col4a3tm1Jhm/Col4a3tm1Jhm
Tg(Nphs1-rtTA*3G)8Jhm/0
Tg(tetO-COL4A3/Col4a3)#aJhm/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Jhm mutation (1 available); any Col4a3 mutation (60 available)
Tg(Nphs1-rtTA*3G)8Jhm mutation (0 available)
Tg(tetO-COL4A3/Col4a3)#aJhm mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
N
• doxycycline-treated mice survive beyond 32 weeks unlike Col4a3tm1Jhm homozygotes

renal/urinary system
N
• doxycycline-treated mice remain nonalbuminuric for months unlike Col4a3tm1Jhm homozygotes
• doxycycline-treated mice do not exhibit glomerulosclerosis or tubular protein cast unlike Col4a3tm1Jhm homozygotes
• some doxycycline-treated mice do not maintain podocyte foot process architecture
• however, many doxycycline-treated mice maintain podocyte foot process architecture unlike in Col4a3tm1Jhm homozygotes
• doxycycline-treated mice exhibit some blebs on the glomerulus basement membrane
• doxycycline-treated mice exhibit some of segmental glomerulus basement membrane thickening observed in Col4a3tm1Jhm homozygotes




Genotype
MGI:5559181
cx4
Allelic
Composition
Col4a3tm1Jhm/Col4a3tm1Jhm
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(tetO-COL4A3/Col4a3)#aJhm/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Jhm mutation (1 available); any Col4a3 mutation (60 available)
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy mutation (5 available); any Gt(ROSA)26Sor mutation (942 available)
Tg(tetO-COL4A3/Col4a3)#aJhm mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
N
• doxycycline-treated mice exhibit normal kidney architecture
• doxycycline-treated mice exhibit some of segmental glomerulus basement membrane thickening observed in Col4a3tm1Jhm homozygotes




Genotype
MGI:6378621
cx5
Allelic
Composition
Col4a3tm1Jhm/Col4a3tm1Jhm
Lamb2em1Jhm/Lamb2+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Jhm mutation (1 available); any Col4a3 mutation (60 available)
Lamb2em1Jhm mutation (0 available); any Lamb2 mutation (76 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice show a reduction in survival compared to single Col4a3 homozygotes, with mice starting to die after 4 weeks of age and none surviving past 10 weeks

renal/urinary system
• increase in the urinary albumin-to-creatine ratio (ACR) compared to single Col4a3 homozygotes as early as P7-P11
• although ACR remains high through 7 weeks, it decreases as blood urea nitrogen (BUN) levels increase at 5-7 weeks
• kidneys appear normal at P7-P11 but show histopathologic features at 6-8 weeks of age including glomerulosclerosis, crescents, and tubular protein casts
• mice show a trend of increased foot process effacement at P7-P11 compared to single Col4a3 homozygotes and foot process effacement is significantly worse by 5 weeks of age
• glomerular basement membrane splitting and bulging is seen at early stages, which eventually worsen to become thick
• mice show acceleration of glomerular lesions compared to single Col4a3 homozygotes
• kidneys show glomerular crescents at 6-8 weeks of age

homeostasis/metabolism
• increase in BUN levels at 5-7 weeks of age
• increase in the urinary albumin-to-creatine ratio (ACR) compared to single Col4a3 homozygotes as early as P7-P11
• although ACR remains high through 7 weeks, it decreases as blood urea nitrogen (BUN) levels increase at 5-7 weeks




Genotype
MGI:6378622
cx6
Allelic
Composition
Col4a3tm1Jhm/Col4a3tm1Jhm
Lamb2em1Jhm/Lamb2em1Jhm
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Jhm mutation (1 available); any Col4a3 mutation (60 available)
Lamb2em1Jhm mutation (0 available); any Lamb2 mutation (76 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
• significant foot process effacement is seen at P7-P11
• abnormal glomerular basement membrane ultrastructure
• kidneys show histopathologic features at P7, indicating a worsened Alport phenotype





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory